These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10598194

  • 1. Foregut carcinoids: a clinical and biochemical analysis.
    Kirshbom PM, Kherani AR, Onaitis MW, Hata A, Kehoe TE, Feldman C, Feldman JM, Tyler DS.
    Surgery; 1999 Dec; 126(6):1105-10. PubMed ID: 10598194
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW, Kirshbom PM, Hayward TZ, Quayle FJ, Feldman JM, Seigler HF, Tyler DS.
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [Abstract] [Full Text] [Related]

  • 3. Gastrointestinal carcinoid tumors: factors that predict outcome.
    Van Gompel JJ, Sippel RS, Warner TF, Chen H.
    World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
    [Abstract] [Full Text] [Related]

  • 4. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
    Kirshbom PM, Kherani AR, Onaitis MW, Feldman JM, Tyler DS.
    Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
    Srivastava A, Padilla O, Fischer-Colbrie R, Tischler AS, Dayal Y.
    Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
    [Abstract] [Full Text] [Related]

  • 6. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.
    Hepatogastroenterology; 2005 Oct; 52(63):731-41. PubMed ID: 15966194
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
    Bashir S, Gibril F, Ojeaburu JV, Asgharian B, Entsuah LK, Ferraro G, Crafa P, Bordi C, Jensen RT.
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A, Hornick JL.
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [Abstract] [Full Text] [Related]

  • 9. Clinical presentation and prognosis of gastrointestinal carcinoid tumours.
    Sjöblom SM.
    Scand J Gastroenterol; 1988 Sep; 23(7):779-87. PubMed ID: 3227292
    [Abstract] [Full Text] [Related]

  • 10. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases.
    Mårtensson H, Nobin A, Sundler F.
    Acta Chir Scand; 1983 Sep; 149(6):607-16. PubMed ID: 6650073
    [Abstract] [Full Text] [Related]

  • 11. Carcinoids of the pancreas: an analysis of 156 cases.
    Soga J.
    Cancer; 2005 Sep 15; 104(6):1180-7. PubMed ID: 16104045
    [Abstract] [Full Text] [Related]

  • 12. Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids.
    Tomita T.
    Endocr Pathol; 2001 Sep 15; 12(2):137-45. PubMed ID: 11579679
    [Abstract] [Full Text] [Related]

  • 13. Carcinoid tumors of the gastrointestinal tract.
    Morgan JG, Marks C, Hearn D.
    Ann Surg; 1974 Nov 15; 180(5):720-7. PubMed ID: 4421375
    [Abstract] [Full Text] [Related]

  • 14. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
    Perez EA, Koniaris LG, Snell SE, Gutierrez JC, Sumner WE, Lee DJ, Hodgson NC, Livingstone AS, Franceschi D.
    World J Surg; 2007 May 15; 31(5):1022-30. PubMed ID: 17429568
    [Abstract] [Full Text] [Related]

  • 15. The impact of incidental identification on the stage at presentation of lower gastrointestinal carcinoids.
    Buitrago D, Trencheva K, Zarnegar R, Finnerty B, Aldailami H, Lee SW, Sonoda T, Milsom JW, Fahey TJ.
    J Am Coll Surg; 2011 Nov 15; 213(5):652-6. PubMed ID: 21880512
    [Abstract] [Full Text] [Related]

  • 16. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC, Banner B, Glickman J, Odze RD.
    Hum Pathol; 2001 Oct 15; 32(10):1087-93. PubMed ID: 11679943
    [Abstract] [Full Text] [Related]

  • 17. Carcinoid tumours.
    Tiensuu Janson EM, Oberg KE.
    Baillieres Clin Gastroenterol; 1996 Dec 15; 10(4):589-601. PubMed ID: 9113314
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine tumors of the gastrointestinal tract.
    Chejfec G, Falkmer S, Askensten U, Grimelius L, Gould VE.
    Pathol Res Pract; 1988 Apr 15; 183(2):143-54. PubMed ID: 3290866
    [Abstract] [Full Text] [Related]

  • 19. The visualization of gastroenteropancreatic endocrine tumors.
    Lamberts SW, Chayvialle JA, Krenning EP.
    Digestion; 1993 Apr 15; 54 Suppl 1():92-7. PubMed ID: 8395433
    [Abstract] [Full Text] [Related]

  • 20. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
    Nilsson O, Kölby L, Wängberg B, Wigander A, Billig H, William-Olsson L, Fjälling M, Forssell-Aronsson E, Ahlman H.
    Br J Cancer; 1998 Feb 15; 77(4):632-7. PubMed ID: 9484822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.